Key facts
- Jade Biosciences Inc. filed a Form 424B5 on June 4th.
- The filing is a prospectus supplement.
Jade Biosciences Inc. submitted a Form 424B5 filing to the U.S. Securities and Exchange Commission on June 4th. This type of filing is known as a prospectus supplement, which is used to provide additional information or updates to an already filed prospectus for securities offerings. The filing itself does not typically contain new financial data but serves as an addendum to existing registration statements.
